TAG's most important fundraising event of the year, our Research in Action Awards (RIAA), will take place on Thursday, October 15, 2026, at the Angel Orensanz Foundation, 172 Norfolk Street, New York City, from 6-9 p.m. Save the date or get your tickets now!
Storytelling is a tool that can help build understanding, support discussions between members of affected communities and other stakeholders, and aid in the identification of important issues and potential solutions. These storyboards follow three individuals journeys through diagnosis, treatment and care, and the barriers they face.
On June 4, 2025, the Cure Hepatitis C Act of 2025/2026 (S.1941/H.R.9682) was introduced with bipartisan cosponsorship in both chambers. While this is the most comprehensive hepatitis C virus (HCV) specific bill ever introduced in Congress, it requires significant changes…
Treatment Action Group (TAG) welcomes the introduction of the House companion to the Cure Hepatitis C Act (S.1941) and applauds Representatives Diana DeGette (D-CO), Mariannette Miller-Meeks (R-IA), Hank Johnson (D-GA), and Don Bacon (R-NE) for advancing bipartisan legislation to eliminate hepatitis C in the United States. We are particularly encouraged that the House bill removes the immigration-based eligibility restrictions contained in Section 10 of the Senate version — an important improvement that brings the legislation closer to the public health principles necessary to achieve hepatitis C virus (HCV) elimination in the United States in our lifetimes.
TAG and the Global TB CAB have a long history of advocating for the uptake of new health innovations, influencing global and national decision-making, and supporting policy translation. In March 2026, the World Health Organization (WHO) recommended a new class of tests — near point-of-care (NPOC) molecular tests — that offer faster, more decentralized, cheaper, and more accessible TB diagnosis
Treatment Action Group (TAG) has submitted formal comments opposing a proposed rule from the White House Office of Management and Budget (OMB) that would overhaul how federal research grants are awarded and managed. Under the proposed rule changes, scientific experts would still review research applications, but political appointees would have final authority to approve, deny, or cancel awards based on alignment with the administration's priorities.
Poetry can be used as a form of public health. In a recently written poem, LAT CAB member Bakyt Myrzaliev speaks about the trials and tribulations of tuberculosis treatment – writing passionately and inquisitively about side effects, the high burden of countless pills, and ultimately calling for investments into newer forms of treatment. Treatment Action Group (TAG) and the African Community Advisory Board (AfroCAB) formed the Long-Acting Technologies Community Advisory Board (LAT CAB) to implement meaningful, equitable solutions and research to serve communities that need them the most. LAT CAB is a dedicated community body that will advance LAT research and uptake under the Unitaid-funded LONGEVITY project.
The WHO Global TB Program's Accelerator Platform for Novel TB Regimens held its 12th meeting to examine the four-month HPMZ (isoniazid, rifapentine, moxifloxacin, pyrazinamide) regimen for tuberculosis treatment, covering country experiences, implementation tools, and next steps for rollout. Despite the World Health Organization's (WHO) 2022 recommendation, implementation has remained limited, with challenges such as high pill burden and medicine costs cited as potential barriers.
Treatment Action Group (TAG) is seeking a consultant to coordinate and strengthen the work of the Community Research Advisors Group (CRAG), one of the longest-running community advisory boards in tuberculosis (TB) research.
This year marks our 6th Annual Pride Health Fair — a necessary act of political resistance in response to attacks on healthcare, LGBTQIA+ communities, and human dignity. As healthcare becomes unaffordable, this event remains a opportunity to access care while building community power.
The Research in Action Awards are on Thursday, October 15 from 6-9 p.m. at The Angel Orensanz Foundation, 172 Norfolk St., in the Lower East Side. TAG’s premier fundraising event honors the brightest scientists, activists, and artists working to end HIV, TB, and HCV.
Learn more and buy tickets now!
